[1]ZHANG JJ,TANG KY,FANG RQ,et al.Nanotechnological strategies to increase the oxygen content of the tumor[J].Frontiers Pharmacology,2023,14:1140362.
[2]ANA BELEN HERRERA-CAMPOS,ESTEBAN ZAMUDIO-MARTINEZ,DANIEL DELGADO-BELLIDO,et al.Implications of hyperoxia over the tumor microenvironment:An overview highlighting the importance of the immune system[J].Cancers(Basel),2022,14(11):2740.
[3]ROSA MOLFETTA,SARA PETILLO,MARCO CIPPITELLI,et al.SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses[J].Frontiers Cell Development Biology,2023,11:1213114.
[4]VENKATA PRASUJA NAKKA,ABDUL QADEER MOHAMMED.A critical role for ISGylation,Ubiquitination and,SUMOylation in brain damage:Implications for neuroprotection[J].Neurochemistry Research,2020,45(9):1975-1985.
[5]WANG C,CHENG TT,LU QQ,et al.Oxygen therapy accelerates apoptosis induced by selenium compounds via regulating Nrf2/MAPK signaling pathway in hepatocellular carcinoma[J].Pharmacology Research,2023,187:106624.
[6]KENNETH N HUYNH,SRIRAM RAO,BRADLEY ROTH,et al.Targeting hypoxia-inducible factor-1α for the management of hepatocellular carcinoma[J].Cancers(Basel),2023,15(10):2738.
[7]MA YL,LIU Z.Role of hypoxia-induced extracellular vesicles in tumor development[J].Modern Oncology,2020,28(12):2155-2158.
[8]XIA SJ,PAN Y,LIANG YL,et al.The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma[J].Biology Medicine,2020,51:102610.
[9]GUO Y,XIAO ZQ,YANG L,et al.Hypoxia-inducible factors in hepatocellular carcinoma[J].Oncology Reports,2020,43(1):3-15.
[10]QI ZF,YUAN SH,LIU KJ,et al.Normobaric hyperoxia plays a neuroprotective role after cerebral ischemia by maintaining the redox homeostasis and the level of connexin 43 in astrocytes[J].CNS Neuroscience Therapy,2022,28(10):1509-1518.
[11]HUIB OVAA,ALFRED CO VERTEGAAL.Probing ubiquitin and SUMO conjugation and deconjugation[J].Biochemistry Society Transactions,2018,46(2):423-436.
[12]JEREMY M HENLEY,RUTH E CARMICHAEL,KEVIN A WILKINSON.Extranuclear SUMOylation in neurons[J].Trends in Neurosciences,2018,41(4):198-210.
[13]ZHU QH,LIANG PP,CHU CY,et al.Protein sumoylation in normal and cancer stem cells[J].Frontiers in Molecular Biosciences,2022,9:1095142.
[14]ZENG M,LIU WH,HU Y,et al.Sumoylation in liver disease[J].Clinica Chimica Acta,2020,510:347-353.
[15]CHANG HM,EDWARD TH YEH.SUMO:From bench to bedside[J].Physiological Reviews,2020,100(4):1599-1619.
[16]FABIO CICCARONE,SERENA CASTELLI,MARIA ROSA CIRIOLO.Oxidative stress-driven autophagy acROSs onset and therapeutic outcome in hepatocellular carcinoma[J].Oxidative Medicine and Cellular Longevity,2019,8:6050123.
[17]CAROLINA MENDEZ-BLANCO,FLAVIA FONDEVILA,ANDRES GARCIA-PALOMO,et al.Sorafenib resistance in hepatocarcinoma:Role of hypoxia-inducible factors[J].Exp Mol Med,2018,50(10):1-9.
[18]LIU GD,ZHOU SF,DING XC,et al.Soluble expression of recombinant cMyc,Klf4,Oct4,and Sox2 proteins in bacteria and transduction into living cells[J].International Journal of Ophthalmology,2017,10(4):560-566.
[19] JIANG ZM,ZHANG CY,LIU XZ,et al.Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF-1α and Oct4[J].International Journal of Oncology,2020,57(3):780-790.